Co-immunoprecipitation and glutathione S-transferase (GST) pull-down assays demonstrated that MEG2 directly interacts with STAT3 in vitro, and this interaction was confirmed in in vivo mouse brain tissue and human breast cancer cells. Here, STAT3 is linked to breast carcinoma.